Clinical outcomes in methicillin-resistant Staphylococcus aureus-colonized neonates in the neonatal intensive care

Young Hee Kim1, Sung Soo Chang, Yang Soo Kim

  • 1Division of Neonatology, Department of Pediatrics, Clinical Research Center, University of Ulsan College of Medicine, Seoul, Korea.

Neonatology
|June 15, 2007
PubMed
Abstract

Insights

Most neonates (newborn infants) colonized with methicillin-resistant Staphylococcus aureus (MRSA) eventually decolonize, even if carriage is prolonged. Concurrent nasal and inguinal colonization at admission was linked to longer MRSA carriage in NICU infants.

Area of Science:

  • Neonatal Intensive Care Unit (NICU) research
  • Infectious disease epidemiology
  • Microbiology

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) colonization can persist long-term in adults, influenced by patient factors.
  • Limited data exists on MRSA carriage duration and outcomes specifically in neonates.

Purpose of the Study:

  • To investigate the outcomes of MRSA-colonized neonates in the NICU.
  • To determine MRSA incidence, colonization duration, clinical outcomes, and risk factors for prolonged carriage in neonates.
  • To track colonized neonates until decolonization over a 39-month period.

Main Methods:

  • Prospective follow-up of MRSA-colonized neonates in the NICU until decolonization.
  • Nasal and inguinal cultures for MRSA screening upon admission.
  • Weekly or bi-monthly cultures to monitor decolonization status.

Main Results:

  • 10.4% of neonates acquired MRSA colonization, with a mean acquisition time of 17.1 days.
  • Median decolonization time was 36 days; 20% experienced prolonged carriage (>160 days).
  • Concurrent nasal and inguinal colonization was the sole risk factor for prolonged carriage; no prolonged carriage cases developed MRSA infections post-discharge.

Conclusions:

  • Most neonates achieve MRSA decolonization, either before or after NICU discharge.
  • A notable proportion of neonates remain colonized at discharge but decolonize within 30 months in the community.
  • No MRSA-related infections were observed in neonates with prolonged carriage within six months post-discharge.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...